Skip to main content
. 2018 Dec 16;7(2):e00528. doi: 10.1002/mgg3.528

Table 1.

Association of gene expression (high level) with tumor stage, lymph node, age, gender, and smoking in 516 patients with lung adenocarcinoma (LUAD)

Stage N = 508 ADH1B AGER CCNB1 CENPU CLIC5 FAM189A2 GOLM1 GPM6A
I 277 157 (56.7) 154 (55.6) 117 (47.2) 123 (44.4) 159 (57.4) 159 (57.4) 126 (45.5) 153 (55.2)
II 122 52 (42.6) 53 (43.4) 71 (58.2) 70 (57.4) 56 (45.9) 53 (43.4) 69 (56.6) 56 (45.9)
III 84 31 (36.9) 34 (40.5) 53 (63.1) 47 (56.0) 29 (34.5) 33 (39.3) 50 (59.5) 31 (36.9)
IV 25 12 (48.0) 12 (48.0) 14 (56.0) 15 (60.0) 9 (36.0) 8 (32.0) 10 (40.0) 12 (48.0)
p 0.004 0.034 0.001 0.040 0.001 0.002 0.039 0.022
Lymph node N = 515 ADH1B CCNB1 CENPU CLIC5 COL11A1 FAM189A2 TMEM106B
0 333 181 (54.4) 148 (44.4) 155 (46.5) 182 (54.7) 155 (46.5) 182 (54.7) 150 (45.0)
≥1 182 76 (41.8) 110 (60.4) 103 (56.6) 75 (41.2) 104 (57.1) 75 (41.2) 108 (59.3)
p 0.006 0.001 0.029 0.004 0.022 0.004 0.002
Gender N = 516 ADH1B CCNB1 CENPU FAM107A HMGB3 SLIT3 SRPK1 TNXB
Male 239 107 (44.8) 135 (56.5) 134 (56.1) 104 (43.5) 136 (56.9) 108 (45.2) 135 (56.5) 101 (42.3)
Female 277 151 (54.5) 123 (44.4) 124 (44.8) 154 (55.6) 123 (44.4) 151 (54.5) 124 (44.8) 157 (56.7)
p 0.027 0.006 0.010 0.006 0.005 0.035 0.008 0.001
Age N = 497 ADH1B CCNB1 CENPU CLIC5 GPM6A
<65 221 94 (42.5) 123 (55.7) 125 (56.6) 86 (38.9) 95 (43.0)
≥65 276 155 (56.2) 122 (44.2) 120 (43.5) 159 (57.6) 151 (54.7)
p 0.003 0.011 0.004 0.000 0.009
Smoking N = 349 ADAMSTL CENPU EDNRB FAM107A TGFBR3 TMEM106B
<40 pack‐year 172 93 (54.1) 77 (44.8) 98 (57.0) 98 (57.0) 88 (51.2) 65 (37.8)
≥40 pack‐year 177 76 (42.9) 107 (60.5) 76 (42.9) 81 (45.8) 69 (39.0) 92 (52.0)
p 0.037 0.003 0.009 0.036 0.022 0.008

p: chi‐square test.